Intellia Therapeutics Inc buy Morgan Stanley
Start price
13.11.23
/
50%
€21.86
Target price
13.11.24
€79.49
Performance (%)
0.78%
Price
06.05.24
€22.03
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Intellia Therapeutics Inc is nearly unchanged. This prediction currently runs until 13.11.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | 7.359% | 7.359% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by Morgan_Stanley for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat